People may need another COVID-19 vaccine booster shot in fall of 2022: Moderna CEO
Moderna, which benefits by repeat inoculations, during its third quarter earnings results said that commercial booster market…
Author
J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
About 180 million Covaxin doses have been administered in India and more than three million doses have been exported or donated
Pfizer to supply US with 10 million more courses of COVID-19 pills
The White House now expects some four million treatment courses of the pills to be available by the end of January and 10 million…
Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill
The overall cost for a patient treated with a five-day course of 40 capsules of the generic drug, to be sold under brand name…
Interval between Moderna COVID-19 vaccine second shot and booster still six months: FDA
"Right now, if you got J&J, you get a booster after two months, if you got Pfizer as your primary series you can get a booster…
Britain approves Pfizer’s anti-viral COVID-19 pill Paxlovid
Based on data, the pill, Paxlovid, is most effective when taken during the early stages of COVID-19, Britain's Medicines and…
UAE approves Sinopharm’s protein-based vaccine
The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group (CNBG),…
South Korea gives EUA for Pfizer’s oral coronavirus treatment
Paxlovid will be used for adults or children 12 years or older weighing over 40 kg with mild to moderate symptoms with a high risk…
China CanSinoBIO’s vaccine 57.5 per cent effective against COVID in phase-III trial: Study
The single-shot Ad5-nCoV vaccine, which CanSinoBIO co-developed with the Chinese military-backed Beijing Institute of…